KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Equity Ratio (2016 - 2025)

Abbott Laboratories' Equity Ratio history spans 17 years, with the latest figure at 0.61 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 374.83% year-over-year to 0.61; the TTM value through Sep 2025 reached 0.61, up 374.83%, while the annual FY2024 figure was 0.59, 19035.4% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.61 at Abbott Laboratories, up from 0.0 in the prior quarter.
  • Across five years, Equity Ratio topped out at 3.37 in Q4 2021 and bottomed at 1.91 in Q4 2022.
  • The 5-year median for Equity Ratio is 0.0 (2025), against an average of 0.14.
  • The largest annual shift saw Equity Ratio plummeted 41062.89% in 2021 before it skyrocketed 19035.4% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 3.37 in 2021, then tumbled by 156.59% to 1.91 in 2022, then surged by 100.16% to 0.0 in 2023, then surged by 19035.4% to 0.59 in 2024, then grew by 4.02% to 0.61 in 2025.
  • Per Business Quant, the three most recent readings for ABT's Equity Ratio are 0.61 (Q3 2025), 0.0 (Q1 2025), and 0.59 (Q4 2024).